2021
Current US Policy for Opioid Prescribing
Shah A, Haddad D, Vadivelu N, Rajput K. Current US Policy for Opioid Prescribing. 2021, 29-41. DOI: 10.1007/978-3-030-55262-6_3.ChaptersRecent policy initiativesLate nineteenth-century United StatesCurrent US policyNineteenth-century United StatesUnited StatesUS policyPolicy initiativesPresent-day roleNumerous federal regulationsLocal levelFederal initiativesOpioid policyIndividual statesMedical practice standardsHistorical groundworkPolicyDisciplinary actionBest practicesRegulatory bodiesInitiativesPrescription drug monitoring programsState medical boardsOpioid-related harmsFederal regulationsPrescription opioid epidemic
2020
Opioid2FHIR: A system for extracting FHIR-compatible opioid prescriptions from clinical text
Wang J, Mathews W, Pham H, Xu H, Zhang Y. Opioid2FHIR: A system for extracting FHIR-compatible opioid prescriptions from clinical text. 2020, 00: 1748-1751. DOI: 10.1109/bibm49941.2020.9313258.Peer-Reviewed Original ResearchFast Healthcare Interoperability ResourcesInformation extractionNatural language processing techniquesLanguage processing techniquesMedical concept normalizationOpioid informationPost-processing rulesClinical decision supportManual effortConcept normalizationClinical textF-measureNLP applicationsPrescription recordsClinical data standardsData standardsDecision supportFree textProcessing toolsPrescription drug monitoring programsNational public health emergencyProcessing techniquesPrescription opioid overdoseDrug monitoring programsDrug overdose deathsPrescription Drug Monitoring Programs and Prescription Opioid–Related Outcomes in the United States
Puac-Polanco V, Chihuri S, Fink D, Cerdá M, Keyes K, Li G. Prescription Drug Monitoring Programs and Prescription Opioid–Related Outcomes in the United States. Epidemiologic Reviews 2020, 42: 134-153. PMID: 32242239, PMCID: PMC7947593, DOI: 10.1093/epirev/mxaa002.Peer-Reviewed Original ResearchConceptsPrescription drug monitoring programsOpioid-related morbiditySubstance-use disordersOpioid diversionOpioid-related outcomesDrug monitoring programsOpioid-related adverse outcomesMortality rateOpioid prescribing behaviorPrescribing behaviorOutcome domainsState prescription drug monitoring programOpioid-related deathsPDMP implementationOpioid prescriptionsReduce mortality ratesAssociated with reductionsEffects of prescription drug monitoring programsAdverse outcomesOpioidWeb of ScienceOpioid epidemicAssociated with changesDisorder outcomesPDMP characteristicsMeasuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses.
Cerdá M, Ponicki W, Smith N, Rivera-Aguirre A, Davis C, Marshall B, Fink D, Henry S, Castillo-Carniglia A, Wintemute G, Gaidus A, Gruenewald P, Martins S. Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses. Epidemiology 2020, 31: 32-42. PMID: 31596794, PMCID: PMC7027962, DOI: 10.1097/ede.0000000000001123.Peer-Reviewed Original Research
2019
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning
Martins S, Ponicki W, Smith N, Rivera-Aguirre A, Davis C, Fink D, Castillo-Carniglia A, Henry S, Marshall B, Gruenewald P, Cerdá M. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning. International Journal Of Drug Policy 2019, 74: 174-180. PMID: 31627159, PMCID: PMC6897357, DOI: 10.1016/j.drugpo.2019.10.001.Peer-Reviewed Original ResearchConceptsPrescription drug monitoring programsHeroin poisoningLatent transition analysisDrug monitoring programsLatent class membershipPoisoning deathsIllegal opioidsOverdose riskOpioid use disorderPolicy changesPrescribed opioidsHeroinLatent classesPolicy environmentPoisoning rateCounty-level confoundersAdoptionStateUse disorderClass membershipReduced accessEnactmentTransition analysisPoisoning mortalityPrescribing, Prescription Monitoring, and Health Policy
Gordon A, Cochran G, Smid M, Manhapra A, Kertesz S. Prescribing, Prescription Monitoring, and Health Policy. Current Clinical Psychiatry 2019, 223-238. DOI: 10.1007/978-3-030-16257-3_11.Peer-Reviewed Original ResearchOpioid use disorderPrescription drug monitoring programsUse disordersOpioid prescribingOpioid prescriptionsOpioid useOpioid misuseClinical interventionsOpioid-related harmsPrescription opioid useDrug monitoring programsOpioid-related morbidityOpioid addiction epidemicUnited States CentersTreatment of personsPrescribing opioidsChronic painIllicit opioidsCDC guidelinesMedication treatmentPrescription monitoringOpioid epidemicHealth of communitiesAddiction epidemicDisease controlConcomitant Use of Opioids and Benzodiazepines in the Outpatient Setting
Simon J, Gehret J, Stolzenberg D, Beredjiklian P, Teng J, Paskey T, Raju R. Concomitant Use of Opioids and Benzodiazepines in the Outpatient Setting. PM&R 2019, 11: 337-343. PMID: 30884142, DOI: 10.1016/j.pmrj.2018.09.026.Peer-Reviewed Original ResearchPrescription drug monitoring programsOutpatient electronic medical recordsOutpatient settingConcomitant useNumber of opioidElectronic medical recordsOutpatient clinic visitsPatients Prescribed OpioidsAdministration of opioidsDrug monitoring programsOpioid-related deathsClinic visitsCigarette/alcohol useMultiple providersBenzodiazepine prescriptionsMedical recordsProvidersOpioidPatientsBenzodiazepinesPrescriptionMedicationPrescription(sReporting discrepanciesStudy resultsPrescription Drug Monitoring Programs and Opioid Overdoses
Castillo-Carniglia A, Ponicki W, Gaidus A, Gruenewald P, Marshall B, Fink D, Martins S, Rivera-Aguirre A, Wintemute G, Cerdá M. Prescription Drug Monitoring Programs and Opioid Overdoses. Epidemiology 2019, 30: 212-220. PMID: 30721165, PMCID: PMC6437666, DOI: 10.1097/ede.0000000000000950.Peer-Reviewed Original ResearchConceptsPrescription drug monitoring programsOnline prescription drug monitoring programsDrug monitoring programsNoncancer pain conditionsPrescription opioid overdoseMedication accessPain conditionsOpioid overdoseRate of hospital dischargeCounty-level ratesPrescription opioidsHeroin overdoseCounty levelRates of hospitalizationOpioid-related hospitalizationsAssociated with lower ratesMedical providersReduce harmHospital dischargeCounty-levelHierarchical Poisson modelsPrescriptionOpioidPoisson modelHospital
2018
A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016
Smith N, Martins S, Kim J, Rivera‐Aguirre A, Fink D, Castillo‐Carniglia A, Henry S, Mooney S, Marshall B, Davis C, Cerdá M. A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016. Addiction 2018, 114: 248-258. PMID: 30207015, PMCID: PMC6314884, DOI: 10.1111/add.14440.Peer-Reviewed Original ResearchConceptsPrescription drug monitoring programsDrug monitoring programsLatent transition analysisBurden of opioid overdoseMonitoring programsPDMP usersPrescription drug monitoring program dataConcomitant use of opioids and benzodiazepines in the outpatient setting: A retrospective study.
Simon J, Gehret J, Stolzenberg D, Beredjiklian P, Teng J, Paskey T, Raju R. Concomitant use of opioids and benzodiazepines in the outpatient setting: A retrospective study. PM&R 2018 PMID: 30243999, DOI: 10.1016/j.pmrj.2018.09.026.Peer-Reviewed Original ResearchPrescription drug monitoring programsOutpatient electronic medical recordsOutpatient settingConcomitant useNumber of opioidElectronic medical recordsOutpatient clinic visitsPatients Prescribed OpioidsAdministration of opioidsDrug monitoring programsClinic visitsMultiple providersCigarette/alcohol useBenzodiazepine prescriptionsOpioid related deathsRetrospective studyMedical recordsProvidersOpioidBenzodiazepinesPatientsRelated deathsPrescriptionMedicationPrescription(sAssociation Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review.
Fink D, Schleimer J, Sarvet A, Grover K, Delcher C, Castillo-Carniglia A, Kim J, Rivera-Aguirre A, Henry S, Martins S, Cerdá M. Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review. Annals Of Internal Medicine 2018, 168: 783-790. PMID: 29801093, PMCID: PMC6015770, DOI: 10.7326/m17-3074.Peer-Reviewed Original ResearchConceptsPrescription drug monitoring programsPDMP implementationRisk of biasProvider reviewDrug monitoring programsProQuest DissertationsFatal overdoseScience Citation IndexGraded strength of evidencePrescription drug monitoring program dataLow-strength evidenceStrength of evidenceSocial Science Citation IndexFatal drug overdosesCurrent Contents ConnectProgram featuresPotential unintended consequencesCitation IndexNational Institute on Drug AbuseFrequency of reportingUnintended consequencesPain clinic lawsSystematic reviewInclusion criteriaOpioid overdosePromoting Prescription Drug Monitoring Programs for Population Health: Research and Policy Implications
Fink D, Schleimer J, Sarvet A, Grover K, Delcher C, Kim J, Castillo-Carniglia A, Rivera-Aguirre A, Henry S, Cerdá M, Martins S. Promoting Prescription Drug Monitoring Programs for Population Health: Research and Policy Implications. 2018, 206-226. DOI: 10.5040/9798216000600.0015.Peer-Reviewed Original ResearchNational health emergencyPrescription drug monitoring programsDrug monitoring programsPopulation healthMisuse issuesPrescription drug abusePain managementPrevalence of drug abuseOpioid misuseMisused medicationsPrescription misusePublic healthSubstance useHealth emergencyMedication abusePrescriptionDrug abuseMedical environmentPublic policy—andHealthMisuseUnited StatesMedicinePolicy—andU.S. policy
2017
Past‐year Prescription Drug Monitoring Program Opioid Prescriptions and Self‐reported Opioid Use in an Emergency Department Population With Opioid Use Disorder
Hawk K, D'Onofrio G, Fiellin DA, Chawarski MC, O'Connor PG, Owens PH, Pantalon MV, Bernstein SL. Past‐year Prescription Drug Monitoring Program Opioid Prescriptions and Self‐reported Opioid Use in an Emergency Department Population With Opioid Use Disorder. Academic Emergency Medicine 2017, 25: 508-516. PMID: 29165853, PMCID: PMC5963969, DOI: 10.1111/acem.13352.Peer-Reviewed Original ResearchConceptsPrescription drug monitoring programsOpioid use disorderNonmedical prescription opioid usePrescription opioid useAberrant drug-related behaviorsOpioid useOpioid prescriptionsUse disordersED patientsDrug-related behaviorsPrescription recordsState prescription drug monitoring programStatistical Manual IV criteriaNonmedical opioid useRandomized clinical trialsEmergency department assessmentEmergency department populationDrug monitoring programsCharacteristics of participantsUrban EDOpioid dependencePrescription opioidsPDMP dataTreatment trialsClinical history
2016
Potential benefits and harms of prescription opioids in HIV
Becker W, Edelman E. Potential benefits and harms of prescription opioids in HIV. 2016, 113-122. DOI: 10.1002/9781118777374.ch11.ChaptersAntiretroviral therapyPrescription opioidsPrescription drug monitoring programsTrials of opioidsUrine toxicology testingDrug monitoring programsPeripheral nervous systemSubstance use disordersNonpharmacologic modalitiesOpioid prescribingPharmacologic treatmentOpioid analgesicsPain managementPain treatmentMedication adherenceAdequate dosesAntiretroviral adherenceTreatment agreementsSafe prescribingUse disordersNervous systemOpioidsHIVPatientsSubstance use
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply